Arizona State University is shopping at the “smart” store to extend and further research for personalized medicine. The new lab is to be completed in June to be complete with robots. BD
Arizona State University's Biodesign Institute has landed a Harvard Medical School scientist to launch a cutting-edge research lab that aims to pursue more accurate ways to diagnose and treat diseases such as breast cancer and diabetes.
Joshua LaBaer, a Phoenix native who now serves as director of Harvard Medical School's Institute of Proteomics, will relocate his lab to the Biodesign Institute as director of the new Virginia G. Piper Center for Personalized Diagnostics.
LaBaer was lured back home by the promise of Arizona's ambition to advance personalized-medicine research and the Virginia G. Piper Charitable Trust's pledge of $10 million to support his lab and other personalized-medicine efforts. Biodesign Institute also will fund the lab, lend equipment and provide an 8,000-square-foot space.
Piper Trust will commit another $25 million to the Translational Genomics Research Institute (TGen) as part of the personalized-medicine initiative.
Flinn Foundation also will contribute $10 million for TGen's personalized-medicine initiative. The private research lab in downtown Phoenix is now building a new lab for personalized medicine at its downtown campus. The group expects to announce the hiring of a scientist to head the lab this spring.